Katie Obermeyer

Katie Obermeyer is a seasoned professional in biostatistics with extensive experience in the pharmaceutical industry. Currently serving as the Director of Biostatistics for Rare Disease at Amgen since October 2023, Katie has also held the position of Director of Biostatistics at Horizon from February 2017. Prior to this, Katie worked at Advanced Clinical as a Manager and Senior Statistician from December 2012 to February 2017 and started the career at AbbVie, progressing from Associate Statistician to Statistician II between June 2006 and November 2012. Academically, Katie holds a Master's degree in Statistics from Iowa State University and a Bachelor of Science in Mathematics from Truman State University.